CG
BCLI
CFO4Life Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12,000
| Closed | -$40K | – | 147 |
|
|
2022
Q1 | $40K | Hold |
12,000
| – | – | 0.01% | 155 |
|
|
2021
Q4 | $48K | Hold |
12,000
| – | – | 0.01% | 154 |
|
|
2021
Q3 | $40K | Sell |
12,000
-3
| -0% | -$10 | 0.01% | 141 |
|
|
2021
Q2 | $46K | Hold |
12,003
| – | – | 0.01% | 140 |
|
|
2021
Q1 | $46K | Hold |
12,003
| – | – | 0.01% | 144 |
|
|
2020
Q4 | $54K | Hold |
12,003
| – | – | 0.02% | 140 |
|
|
2020
Q3 | $203K | Hold |
12,003
| – | – | 0.07% | 121 |
|
|
2020
Q2 | $135K | Buy |
12,003
+3
| +0% | +$34 | 0.05% | 122 |
|
|
2020
Q1 | $56K | Hold |
12,000
| – | – | 0.03% | 112 |
|
|
2019
Q4 | $51K | Buy |
+12,000
| New | +$51K | 0.02% | 127 |
|